Literature DB >> 23456509

Evaluation of choroidal and retinal thickness measurements using optical coherence tomography in non-diabetic haemodialysis patients.

Fatih Ulaş1, Ümit Doğan, Asena Keleş, Muhittin Ertilav, Hikmet Tekçe, Serdal Celebi.   

Abstract

The aim of this study is to evaluate the effects of haemodialysis with a high ultrafiltration rate on the choroidal and retinal thickness of non-diabetic end-stage chronic renal failure (CRF) patients using optical coherence tomography (OCT). Twenty-one eyes of 21 male CRF patients aged between 46 and 80 years were included in this prospective study. Retinal and choroidal thicknesses of the patients were measured using high-resolution OCT line scans with the activated enhanced depth imaging mode before and shortly after haemodialysis. Retinal and choroidal thickness measurements were taken at the fovea and at two points that were 1,500 μm nasal and temporal to the fovea. The relationships between the haemodynamic changes, intraocular pressure (IOP) and central corneal thickness (CCT) were also evaluated. The mean choroidal thicknesses before haemodialysis at the subfoveal, temporal and nasal locations were 232.81 ± 71.92, 212.43 ± 70.50 and 182.14 ± 68.88 μm, respectively. The mean choroidal thicknesses after haemodialysis at the subfoveal, temporal and nasal locations were 210.90 ± 65.53, 195.38 ± 66.48 and 165.19 ± 66.73 μm, respectively. There were significant differences between the choroidal thicknesses before and after haemodialysis (p < 0.001 for all). The mean retinal thicknesses before haemodialysis at the foveal, temporal and nasal locations were 215.86 ± 41.06, 308.86 ± 37.73 and 338.00 ± 33.32 μm, respectively. The mean retinal thicknesses after haemodialysis at the foveal, temporal and nasal locations were 216.90 ± 39.70, 313.86 ± 32.89 and 335.29 ± 36.85 μm, respectively. There was no significant difference between the retinal thicknesses before and after haemodialysis (p > 0.05 for all). The mean CCT decreased insignificantly from 550.48 ± 17.46 to 548.10 ± 21.12 μm (p = 0.411). The mean IOP decreased significantly from 14.09 ± 2.58 to 12.54 ± 2.23 mmHg (p = 0.003), which did not correlate with the CCT [r = (-)0.134, p = 0.562]. Haemodialysis with a high ultrafiltration volume did not alter the retinal thickness but caused a significant choroidal thinning and an IOP decrease in non-diabetic end-stage CRF patients.

Entities:  

Mesh:

Year:  2013        PMID: 23456509     DOI: 10.1007/s10792-013-9740-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  24 in total

1.  Measurement of foveal thickness by optical coherence tomography in adult haemodialysis patients with diabetic nephropathy.

Authors:  I Auyanet; L J Rodríguez; E Bosch; A Y Sánchez; N Esparza; M M Lago; A Ramírez; M D Checa
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

2.  High-resolution ultrasonic imaging of the posterior segment.

Authors:  D Jackson Coleman; Ronald H Silverman; Almira Chabi; Mark J Rondeau; K Kirk Shung; Jon Cannata; Harvey Lincoff
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

3.  Determination of the effect of a single hemodialysis session on retrobulbar blood hemodynamics by color Doppler ultrasonography.

Authors:  O Tosun; B Davutluoglu; K Arda; M Boran; A Yarangumeli; A Kurt; D Ozkan
Journal:  Acta Radiol       Date:  2007-09       Impact factor: 1.990

4.  Effect of hemodialysis (HD) on intraocular pressure, ocular surface, and macular change in patients with chronic renal failure. Effect of hemodialysis on the ophthalmologic findings.

Authors:  Ji Won Jung; Myung Hun Yoon; Seoung Woo Lee; Hee Seung Chin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-03       Impact factor: 3.117

5.  Intraocular pressure fluctuations during regular hemodialysis and ultrafiltration.

Authors:  H Leiba; M Oliver; M Shimshoni; Y Bar-Khayim
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-06

6.  Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes.

Authors:  Takamitsu Fujiwara; Yutaka Imamura; Ron Margolis; Jason S Slakter; Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

Review 7.  Symptomatic hypotension during hemodialysis.

Authors:  L W Henderson
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

Review 8.  Ocular problems in the patient with end-stage renal disease.

Authors:  Gaia Mullaem; Mitchell H Rosner
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

9.  Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy.

Authors:  Ryo Inoue; Miki Sawa; Motokazu Tsujikawa; Fumi Gomi
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

10.  Moving the retina: choroidal modulation of refractive state.

Authors:  J Wallman; C Wildsoet; A Xu; M D Gottlieb; D L Nickla; L Marran; W Krebs; A M Christensen
Journal:  Vision Res       Date:  1995-01       Impact factor: 1.886

View more
  20 in total

1.  Evaluation of choroidal thickness using spectral-domain optical coherence tomography in migraine patients during acute migraine attacks: a comparative study.

Authors:  A Karalezli; C Simsek; G Celik; F C Eroglu
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

2.  Choroidal thickness changes in patients with pseudoexfoliation syndrome.

Authors:  Mehmet Ozgur Zengin; Esat Cinar; Eyyup Karahan; Ibrahim Tuncer; Sami Yilmaz; Tolga Kocaturk; Cem Kucukerdonmez
Journal:  Int Ophthalmol       Date:  2014-07-25       Impact factor: 2.031

3.  Evaluation of choroidal and retinal thickness measurements in haemodialysis patients.

Authors:  Colin S H Tan; Kai Xiong Cheong
Journal:  Int Ophthalmol       Date:  2014-02-16       Impact factor: 2.031

4.  The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure.

Authors:  Fariba Shaikhi Shoshtari; Sasan Biranvand; Leila Rezaei; Nader Salari; Nasrin Aghaei
Journal:  Int Ophthalmol       Date:  2021-03-19       Impact factor: 2.031

5.  Effect of Hemodialysis on Retinal Thickness in Patients with Diabetic Retinopathy, with and without Macular Edema, Using Optical Coherence Tomography.

Authors:  Nur Azem; Oriel Spierer; Meital Shaked; Meira Neudorfer
Journal:  J Ophthalmol       Date:  2014-09-15       Impact factor: 1.909

6.  Effect of hemodialysis on visual acuity, intraocular pressure, and macular thickness in patients with chronic kidney disease.

Authors:  Elias Chelala; Ali Dirani; Ali Fadlallah; Elise Slim; Youssef Abdelmassih; Henry Fakhoury; Patrick Baz; Riad Bejjani
Journal:  Clin Ophthalmol       Date:  2015-01-09

7.  Evaluation of the acute effect of haemodialysis on retina and optic nerve with optical coherence tomography.

Authors:  Sinan Emre; Anıl Öztürkeri; Mahmut Oğuz Ulusoy; Cem Cankurtaran
Journal:  Saudi J Ophthalmol       Date:  2016-11-08

8.  Effects of hemodialysis on macular and retinal nerve fiber layer thicknesses in non-diabetic patients with end stage renal failure.

Authors:  Cemile U Atilgan; Dilek Guven; Ozge P Akarsu; Tamer Sakaci; Selam Y Sendul; Yasemin Baydar; Kadir G Atilgan; Ibrahim C Turker
Journal:  Saudi Med J       Date:  2016-06       Impact factor: 1.484

9.  The Acute Effect of Hemodialysis on Choroidal Thickness.

Authors:  Osman Çelikay; Sinan Çalışkan; Tolga Biçer; Naciye Kabataş; Canan Gürdal
Journal:  J Ophthalmol       Date:  2015-10-29       Impact factor: 1.909

10.  Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction.

Authors:  Craig Balmforth; Job Jmh van Bragt; Titia Ruijs; James R Cameron; Robert Kimmitt; Rebecca Moorhouse; Alicja Czopek; May Khei Hu; Peter J Gallacher; James W Dear; Shyamanga Borooah; Iain M MacIntyre; Tom Mc Pearson; Laura Willox; Dinesh Talwar; Muriel Tafflet; Christophe Roubeix; Florian Sennlaub; Siddharthan Chandran; Baljean Dhillon; David J Webb; Neeraj Dhaun
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.